Akoya Biosciences, Inc.
AKYA
$1.15
-$0.01-0.86%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -90.90% | 22.16% | 19.90% | 44.01% | -117.40% |
| Total Depreciation and Amortization | -2.92% | 1.48% | -5.24% | -6.09% | -2.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22.21% | 55.38% | -53.65% | -55.01% | 110.00% |
| Change in Net Operating Assets | 521.74% | 121.19% | 36.96% | 53.89% | -653.67% |
| Cash from Operations | -141.92% | 67.78% | 16.17% | 46.98% | -272.92% |
| Capital Expenditure | 80.42% | -140.09% | -155.29% | 79.01% | -36.36% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 335.02% | -72.24% | 45.85% | 119.21% | -- |
| Cash from Investing | 495.77% | -79.31% | 43.79% | 118.55% | -8,118.35% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 64.14% | -202.41% | 4.05% | 4.42% | -0.56% |
| Issuance of Common Stock | -56.25% | 0.00% | -30.43% | -36.11% | 414.29% |
| Repurchase of Common Stock | -- | -- | 100.00% | 56.38% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -1,173.33% | -- |
| Cash from Financing | 48.56% | -224.00% | 92.94% | -378.60% | -104.01% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,207.10% | -121.45% | 187.86% | 94.13% | -1,530.60% |